
US biopharma firm Cubist Pharmaceuticals has named Robert Perez as its chief executive and who will begin the role from …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

